pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 4·1 min read
save

Health secretary RFK Jr. faces staffing gaps as top priority over vaccine initiatives

Jun 4, 2026·read at STAT ↗Neutral

Robert F. Kennedy Jr., in his second year as the nation’s health secretary, has spent much of the first half of the year traveling to farms, clinics and other sites across the United States.

In interviews he has emphasized that the biggest hurdle for his department is filling vacant positions, arguing that staffing shortages are a more pressing issue than accelerating vaccine programs.

The article also points out that recent rule changes are bringing more political influence into the National Institutes of Health, further complicating the agency’s work.

While noting his background as a former Trump surrogate, the piece focuses on the administrative challenges that dominate his agenda.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: RFK Jr.’s second year: Vacancies, not vaccines”

read at STAT ↗
453 words · retrieved Jun 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Legend Biotech CorpNational Institutes of HealthUltragenyx Pharmaceutical Inc.
topics
Vaccines2CardiologyRare DiseaseVaccine

related stories

  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • 15h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 3d agoSTAT+: Can a pregnancy hormone steer a cardiovascular treatment?STAT
  • 3d agoSTAT+: After a rough stretch, mRNA gets a boost — at least for nowSTAT
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT